生命科学资讯

Tenaya, Alnylam ink research collab to find gene targets for cardio drugs

Pressure builds as back-and-forth between uniQure and FDA intensifies

Alltrna undergoes third layoff round before entering clinic, cutting 35% of jobs

Daiichi Sankyo pens pact with Germany's Gaia to sell digital therapeutic for high cholesterol

VC firm to open 30K-square-foot biotech incubator in Salt Lake City

BCI retinal implant medtech Science closes major $230M series C round

PepGen hit with partial clinical hold, analysts blame 'understaffed FDA'

Guardant hits the road with colon cancer blood test

Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem'

Pfizer's oncology R&D strategy: Jeff Legos on speed, breadth and novel combinations

Nvidia dives deeper into medtech, cancer research with Droplet Biosciences

ARPA-H launches $158M effort to aid first-ever lymphatic system medicines

Bayer tosses 1 Pompe gene therapy from $2B AskBio buyout to focus on alternative option

UK invests $64M to expand clinical trial access to underserved communities

Ono’s Deciphera drops early-stage solid tumor drug for strategic reasons

Teva bags $400M deal with Blackstone to fund Sanofi-partnered IBD drug

Sanofi strikes $1.5B global licensing deal for Sino Biopharm's first-in-class JAK/ROCK asset

New cancer cases prompt Kyowa to discontinue late-stage autoimmune disease program

Theravance halves headcount, ends all R&D work after phase 3 rare disease fail

FDA details rationale for rejecting rare disease gene therapy from Regenxbio